Puma, shares slide after Bernstein cuts Q2 outlook
Published on 06/23/2026 at 16:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 14:24.
Puma (DE0006969603) is under pressure on Tuesday, with Xetra trade and analyst coverage both pointing to a sharp reset in expectations. Investing.com says Bernstein cut its Q2 view and lowered its full-year earnings forecast, while MarketScreener still lists an OUTPERFORM consensus and a 29.25-euro average target.Investing.com report on Bernstein's preview
Bernstein turns cautious
Investing.com quoted Bernstein as expecting a 9 percent constant-currency revenue decline for the second quarter, versus a 6 percent Street estimate. It also cited a cut in full-year EPS to -1.42 euros from -1.30 euros.
What the consensus says
MarketScreener's consensus page shows an OUTPERFORM rating, 28.13 euros as the last close price and 29.25 euros as the average target. The spread versus the target stands at 3.97 percent, which gives the stock a clearly mixed analyst backdrop.MarketScreener consensus page
All news and analysis on the Puma shares
The latest analyst notes, price moves and company updates are collected on one topic page for DE0006969603.
The product behind the stock
Puma sells footwear, apparel and accessories under the Puma brand, with running and football products among the best-known lines. The group also highlighted the Puma Nitro Lab in Los Angeles and the Ultra Nitro 7 football boot in a June 11 market note on MarketScreener.MarketScreener news page
The shares at 16:24
The Puma shares (DE0006969603) trade on 2026-06-23, 16:24 on Xetra at 27.72 euros.
Key data on Puma shares
- Company: PUMA SE
- ISIN: DE0006969603
- Ticker: PUM
- Trading venue: Xetra
- Price (as of 2026-06-23, 16:24): 27.72 euros
- Sector / industry: Consumer Discretionary / Footwear
- Index membership: MDAX
Disclaimer: This article is for information only and does not constitute investment advice.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
